[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Cavaier et al., 2017 - Google Patents

Terbium radionuclides for theranostics applications: a focus on MEDICIS-PROMED

Cavaier et al., 2017

View PDF
Document ID
17639076781234674035
Author
Cavaier R
Haddad F
Sounalet T
Stora T
Zahi I
Publication year
Publication venue
Physics Procedia

External Links

Snippet

A new facility, named CERN-MEDICIS, is under construction at CERN to produce radionuclides for medical applications. In parallel, the MEDICIS-PROMED, a Marie Sklodowska-Curie innovative training network of the Horizon 2020 European Commission's …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G21G2001/0042—Technetium
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/02—Neutron sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1077—Beam delivery systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy

Similar Documents

Publication Publication Date Title
Cavaier et al. Terbium radionuclides for theranostics applications: a focus on MEDICIS-PROMED
Qaim The present and future of medical radionuclide production
Qaim Use of cyclotrons in medicine
Kin et al. New production routes for medical isotopes 64Cu and 67Cu using accelerator neutrons
Inagaki et al. Production of 47 Sc, 67 Cu, 68 Ga, 105 Rh, 177 Lu, and 188 Re using electron linear accelerator
Tárkányi et al. Cross-section measurement of some deuteron induced reactions on 160 Gd for possible production of the therapeutic radionuclide 161 Tb
Bobeica et al. Radioisotope production for medical applications at ELI-NP
Köster et al. Electromagnetic isotope separation of gadolinium isotopes for the production of 152,155 Tb for radiopharmaceutical applications
Abel et al. Production, collection, and purification of 47Ca for the generation of 47Sc through isotope harvesting at the national superconducting cyclotron laboratory
Qaim New directions in nuclear data research for accelerator-based production of medical radionuclides
Tsukada et al. 99Mo yield using large sample mass of MoO3 for sustainable production of 99Mo
Nagai Production scheme for diagnostic-therapeutic radioisotopes by accelerator neutrons
Yang et al. Simulation study on the production of medical radioisotopes 186gRe by photonuclear reaction
Tandon et al. Radiation safety guide for nuclear medicine professionals
Pang et al. Progress of photonuclear cross sections for medical radioisotope production at the SLEGS energy domain
Nagai Medical isotope production using high intensity accelerator neutrons
Gao et al. Production of 99Mo via photoneutron reaction using a 50 MeV electron linear accelerator
US20160379728A1 (en) Yttrium-90 production system and method
Konefał et al. Application of therapeutic linear accelerators for the production of radioisotopes used in nuclear medicine
Gopalakrishna et al. Production of 99 Mo and 64 Cu in a mixed field of photons and neutrons in a clinical electron linear accelerator
Griswold Actinium-225 production via proton irradiation of thorium-232
Mushtaq Radiotherapy in Pakistan
Soleimani et al. Feasibility of 153Sm production using MNSR research reactor through a multi-stage approach
Nagai 99Mo production via 100Mo (n, 2n) 99Mo using accelerator neutrons
Tiba Berdnikov Ya. A